Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantatio
Not Applicable
- Conditions
- refractoty acute GVHD after stem cell transplantation
- Registration Number
- JPRN-C000000423
- Lead Sponsor
- Jichi Medical University, Department of Medicine, Division of Hematology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1) in relapse disease status 2) in unconsciousness 3) in severe infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method GVHD score
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie MSC-mediated immunomodulation in refractory acute GVHD post-transplant?
How does MSC therapy compare to corticosteroids in treating steroid-resistant acute GVHD after hematopoietic stem cell transplantation?
Which biomarkers correlate with MSC treatment response in patients with refractory acute GVHD following allogeneic stem cell transplantation?
What are the long-term safety profiles of MSC administration for acute GVHD in the context of prior stem cell transplantation?
What combination strategies with MSCs and JAK inhibitors show promise for refractory acute GVHD treatment post-transplant?